Mice can be immunized with the isolated capsid components of adenovirus (fibre and hexon) and the antibody response is largely thymus dependent. Immunized mice are protected against challenge with a lethal dose of adenovirus and this protection is type-specific for fibre, and mostly type-specific for hexon. The protection is antibody-mediated and there is an absolute requirement for a detectable level of circulating antibody to be present at the time of challenge. Although cellmediated immunity is insufficient to protect against this particular disease syndrome, the possibility of its importance in protecting against natural adenovirus infection remains.
INTRODUCTION
There is widespread concern about the dangers of introducing potentially oncogenic material when using live or inactivated viruses as vaccines. One way to avoid this is to use only those components of the virus which elicit protective immunity. Virus vaccines may need to elicit cell mediated as well as humoral immunity (Allison, r972) , and it is an important question whether isolated virus components are as effective as whole virus in this regard.
Antisera against whole live human adenovirus can neutralize virus infectivity in tissue culture, and the factors responsible are antibodies to the hexon and fibre antigens of the virus capsid (see Philipson & Pettersson, I973) . Moreover, it has been shown that purified hexon and fibre can elicit antibodies that neutralize virus in vitro (Wilcox & Ginsberg, I963; Kjellen & Pereira, r968 ) . This strongly suggested that the isolated protein subunits should be effective vaccines, and so we have examined the immunogenicity in mice of fibre and hexon as compared with whole virus.
Until recently there has been no animal in which human adenovirus has been known to cause disease, and so the subunit vaccines could only be tested to a limited extent in human volunteers (Couch et aL I973) . However, recent work has provided such a system (Postlethwaite, I973) and has shown that, in mice, intravenous inoculation of about Io ~ p.f.u, of human adenovirus type 5 will cause extensive liver damage resulting in death in 3 to 4 days. There is a very abrupt virus dose threshold; a threefold reduction will produce transient disease with rapid recovery. This is the test system we have used.
Adenoviruses provide a very useful model for testing methods in subunit vaccination, as their structure and replication are relatively well understood, and some of their components can readily be purified. For a recent review of this area see Philipson & Pettersson 0973) . sulphate dropwise. The precipitate was spun down in a bench centrifuge, washed in phosphate-buffered saline (PBS), resuspended at the appropriate concentration, and o.z ml injected i.p. 8o to 9o % of the protein was precipitated by this method.
For immunization with live virus, mice were given o.2 ml in 5 % glycerol by the i.p. route. In this way the equivalent of a lethal dose given i.v. could be administered without any adverse response of the animal.
Standard guinea pig antisera were obtained by inoculation of Io to 5o #g of pure antigen in Freund's complete adjuvant into foot pads (Haase et al. 1972) . The serum was collected 3 weeks later, and inactivated at 56 °C for 3o min.
Antibody assays

Radio-immuno-precipitation assay (RIP).
[125I]-labelled antigens were prepared by the chloramine T method (Hunter & Greenwood, I962) and used to test sera in a modified Farr assay, using anti-globulin serum (Janeway & Sela, I967) ; test sera were serially diluted in normal mouse serum (free of adenovirus antibody) and 5 #1 of each dilution was incubated with 5o #1 of labelled antigen (o'4 #g/ml) at 37 °C for 3o min. Then enough rabbit antimouse immunoglobulin serum was added to precipitate all the mouse immunoglobulin, and the mixture incubated for a further 15 min at 37 °C. The precipitate was washed by addition of o'5 ml diluent (i % BSA in borate buffer, pH 8"4, for hexon, in PBS, pH 7"4, for fibre) and after incubating for 3o rain at 37 °C and I h at 4 °C, the precipitates and supernatant fluids were separated by low speed sedimentation and counted in a Packard Autogamma counter. The results are expressed as the reciprocal of the serum dilution giving 5o % precipitation of labelled antigen.
Radial diffusion test (RDT).
Single radial diffusion assays as described by Pereira, Machado & Schild 097z) were also used to test for anti-fibre and anti-hexon antibodies in mouse sera. High titre sera (5 pl samples) were tested in agar plates using 3 ° #g fibre or 6o #g hexon per plate (equivalent to Io #g/ml fibre or zo #g/ml hexon). For low titre sera we used p25I]-labelled antigens at 1o-or xoo-fold lower concentration and measured zone areas after autoradiography of the dried gel. In the text RDT titres are expressed as zone area (in mm ~) for I #g/ml fibre or z #g/ml hexon.
RESULTS
The antibody response of mice to capsid antigens
Groups of mice were immunized with various doses of hexon and fibre antigens in aqueous or alum precipitated form, and the primary antibody response was measured by RDT or RIP ( Fig. I ; Table I ). Mean titres of groups of 5 to Io mice are shown. Aqueous antigens injected i.p. elicit a very poor response; the hexon is a slightly more potent immunogen than the fibre. However, a similar antigen dose given as an alum precipitate is strongly immunogenic. The results of these and similar experiments (not shown) lead to the following conclusions.
The lowest dose of antigen in alum precipitate that could stimulate antibody production was found to be about o.i #g for hexon and 2 #g for fibre. At the upper limit, a dose of5o #g of both antigens was approaching the plateau of the primary response, but, especially with fibre, somewhat higher antibody levels could be obtained after a boost with aqueous antigen (Fig. I a and c) . The time course of the response is somewhat different for the two antigens, the primary anti-hexon peak being at IO to 15 days, and for the fibre at 2o to 30 days. Very sensitive RIP tests showed that unimmunized mice had very low levels of cross-reacting antibody to hexon, which were presumably related to pre-exposure to a rodent adenovirus, since they were not detected in the sera of specific-pathogen-free mice. Moreover, there was no detectable background antibody to fibre. Tests for increase in anti-hexon antibody in mice immunized with fibre, and vice versa, were negative, indicating purity of the antigens.
The antibody response of mice to intact adenovirus
In order to compare the immunogerticity of subunit preparations with that of antigens in intact virus, we immunized mice with live virus in 5 % glycerol by the i.p. route; Table' 2 shows that hexon is a somewhat more potent immunogen when presented in live virus (assuming I o g p.f.u, of virus to contain about 5/zg hexon); Io/zg of alum precipitated hexon elicits a response of only a third the magnitude of that obtained with whole virus. The situation is more extreme for fibre: Io 9 p.f.u, of virus (equivalent to o.I/zg fibre) elicits antibody levels similar to 4o #g of alum precipitated fibre. In addition, fibre primes particularly well for a secondary response when presented in whole virus form, even when it elicits a rather weak primary response. It seems unlikely that the virus given i.p. multiplies, as the kinetics of the anti-hexon response to whole virus and to isolated antigen are so similar. Furthermore u.v.-inactivated virus is as immunogenic as intact virus (V. Mautner & H. N. A. Willcox, unpublished observations) .
Protection
Immunized and control mice were challenged at various times with a lethal dose of live virus intravenously, and the results are summarized in Table i . The following conclusions can be drawn: immunity to either fibre or hexon can protect the mice against challenge with ~o 9 p.f.u. We have not explored the upper limit of protection by giving doses much greater than the known minimal lethal dose. In general it appears that a low but detectable level of circulating antibody is required for protection. Protection occurs even at day xo in a primary response, when we would expect the antibody to be predominantly of the IgM class. Whether there is an absolute requirement for circulating antibody, or it is merely a sensitive indicator of the overall immune status of the animal (cellular and humoral), was V. MAUTNER AND H. N. A. WILLCOX Groups of 8 thymectomized (Tx), non-thymectomized (non Tx) or normal mice were immunized i.p. with alum precipitated antigens. Booster doses were given (a) on day 2I with I #g aqueous hexon, (b) on day 3I with the priming dose of hexon, but in aqueous form, (c) on day 29 with 5 #g aqueous fibre, or (d) on day 29 with I l~g aqueous fibre. Challenge was on day 4o. Individual sera assayed by RDT against the appropriate antigen (arithmetic means are shown). * Not tested. Thymectomized (Tx), non-thymectomized (non Tx) and normal mice were primed with the stated doses of virus i.p in 5 % glycerol, and were boosted on day 26 with lO s p.f.u, of virus. Individual sera assayed by RDT versus hexon (H) and fibre (F). Arithmetic means are shown: there were 8 mice per group. * Not done.
further examined in adoptive transfer experiments (see below). In addition to the neutralization of the lethal effect of virus by circulating antibody, the antibody titres of protected mice are considerably boosted by the challenge.
Thymus dependency of antibody response to antigens
It was first established that thymectomized mice were no more susceptible to virus than mice with an intact immune system; even with finely graded doses of virus, there was a]barely significant difference in lethal end-point. The thymus dependence of the antibody response to fibre and hexon was then tested at various antigen doses, and the results are Spleen cell suspensions were prepared from donors primed 36 days in advance with Io/zg alum precipitated antigen. 3 × lO 7 cells were transferred i.p., with or without additional antigen, to sublethally irradiated syngeneic recipients, which were challenged 7 days later with a lethal dose (LD) or 3 × LD of live virus. Individual serum antibody titres assayed on day 7 by RDT against fibre in groups I to 3 and hexon in group,; 4 to I I. Arithmetic means are shown.
* Not tested.
shown in Table 3 -Overall, we consistently found at least a tenfold difference in antibody titres between controls and thymectomized mice, and with hexon most of the thymectomized mice had titres less than three times above background. On virus challenge, most thymectomized mice were not protected (Table 3) but there were a few anomalies, in that with high hexon doses, particularly where pertussis was used as adjuvant, some thymectomized mice showed significant antibody responses and survived virus challenge. The main conclusion from these results is that both antigens are largely thymus dependent with respect to antibody production.
Thymus dependency of antibody response to whole virus
The possibility that presentation in whole virus might overcome the thymus dependency of its constituent antigens was also tested (Table 4) . For both antigens, the primary responses in the thymectomized mice were at least ten times lower than in the controls, and thus were largely thymus dependent. However, the thymectomized mice did make significant primary antibody responses to hexon (which were at least ten times their pre-immunization background levels), and their secondary titres to both hexon and fibre were substantial, and considerably higher than thymectomized mice immunized with the isolated antigens.
In view of these responses to whole virus immunization, it is not surprising that the mice were solidly protected against subsequent challenge with a lethal dose of virus.
The requirement for circulating antibody Spleen cell transfers
The experiments described above do not tell us whether protection is antibody-or cellmediated, nor whether a challenge dose of virus can elicit a protective secondary response in primed mice that have no circulating antibody at the time of challenge. One can test whether primed lymphocytes, in the absence of circulating antibody, can protect the mice by using adoptive cell transfers. In this system, primed donor spleen cells are washed 6/6 6/6 4/6 o/6 + 6 o/6 o/6 NT NT + 24 0/6 o[6 NT NT Groups of mice were given 0.2 ml of guinea pig anti-hexon serum (RDT titre 330) diluted with I in 5 normal guinea pig serum at various times intravenously, and challenged with It ~ p.f.u, of virus at time o.
thoroughly to rid them of free antigen and antibody, and then transferred to irradiated recipients. They make no more antibody after transfer unless they are further stimulated by antigen, when they can mount a brisk secondary response.
Cell transfer experiments were carried out as described in the Methods. In some groups, additional antigen was mixed with the ceils at the time of transfer, to elicit high levels of circulating antibody in the recipients. Table 5 shows that, in general, the recipients only made antibody after boosting with the appropriate antigen; exceptionally (in groups 5 and 6) low levels were made even without an antigen boost (presumably due to antigen contamination).
Although all groups received the same numbers of primed cells, only those also boosted with antigen were protected (including groups 5 and 6). Thus the main conclusion is that there is a need for pre-existing antibody to protect the mice. This suggests that cell mediated immunity makes, at most, a very minor contribution to protection under these conditions and that the challenge dose of virus cannot elicit a protective secondary antibody response.
Passive antibody transfers
In order to confirm that circulating antibody was required at the time of virus challenge we carried out passive antibody transfer experiments. We used guinea pig serum raised to isolated hexon, that had been shown to neutralize infectivity in vitro, and furthermore would neutralize virus pre-incubated with it before inoculation into mice. Mice were given an appropriate dose of guinea pig serum either 24 h before or after, or close to the time of challenge with a lethal dose of virus. Controls confirmed that normal guinea pig serum was neither toxic nor protective under the conditions used. It is clear from Table 6 that only if antibody is present at the time of challenge will it be effective in protection, and is ineffective if given 6 h after challenge, presumably because the virus is rapidly taken up from the circulation and is no longer susceptible to serum neutralization. Mice could also be protected with guinea pig antiserum to fibre.
Type-specificity
All adenoviruses of mammalian origin cross react in complement fixation tests, and this reactivity has been attributed to group-specific determinants located on the hexons. Adenoviruses are divided into 'types' on the basis of in vitro virus neutralization, and anti-hexon antibody neutralizes in a type-specific manner (see Norrby, I969). Thus hexons possess at least two distinct antigenic determinants, one common to all viruses in the group and another that is unique to each type. The fibre, in contrast, is type-specific in complement 
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Mice in groups a to c were primed with io#g of alum-precipitated antigen, followed by a i #g booster of antigen in saline on day 31 and a 5 #g booster on day 53. The mice were challenged with a minimal lethal dose (low) or a 2 x lethal dose (high) on day 70. Mice in groups d and e were the survivors of homologous challenge of groups a and b and were re-challenged with heterologous virus on day 80. Groupf were control unimmunized mice.
fixation and in neutralization, although there has been some controversy in the literature as to whether antibody to fibre actually neutralizes virus infectivity (Kjellen & Pereira, I968; Wadell, I972 ).
Protection
The system of protection in mice that we have described affords an opportunity to test the type-specificity of neutralization in vivo. Mice were primed with hexon or fibre of type 2 or 5, and then challenged with the heterologous virus, using the homologous challenge as positive control for protection. As detailed in Table 7 , our findings support the notion that the protective effect of hexon antibody is type-specific, and provide new evidence for type-specificity of anti-fibre neutralization. The type-specificity is not absolute with hexon, and particularly when mice primed by hexon and boosted by homologous challenge were subsequently challenged with heterologous virus, there was significant cross-protection. We cannot distinguish in this experiment whether this was due to antibody to another component of the virus, or was a reflection of the very high anti-hexon titres achieved under those conditions.
DISCUSSION
Our prime object was to investigate the potential of vaccination with purified capsid components, and its ability to protect against challenge with live virus, in the model system in mice. Both hexon and fibre were immunogenic, especially in alum precipitated form, and the specificity and the dose dependency of the responses were demonstrated. Given alone, fibre was found to be much less immunogenic than in whole virus form, whereas with hexon there was less difference between the two forms. Thus, a threshold immunogenic dose of o.I/zg of isolated hexon is roughly equivalent to the hexon content of IO 9 virus particles, which is itself a threshold immunogenic dose in whole virus (V. Mautner & H. N. A. Willcox, unpublished observations) . In contrast, a threshold dose of 2/zg of fibre is roughly equivalent to the fibre content of 2 x io 12 virus particles, which is about IOO times its threshold dose in whole virus. It is possible that whole virus is more immunogenic, even without adjuvant, because, being particulate, it is more easily taken up by macrophages (Schmidtke & Unanue, 1970 , and this facilitates presentation to lymphocytes (Unanue & Askonas, ~968; Panijel & Cayeux, I968) . Alternatively it may be that in aggregated form the antigen directly stimulates lymphocytes more readily, as has been found, for example, with flagellin (Nossal, Ada & Austin, 1964; Feldmann & Basten, 197I ) . We have already discounted the possibility that the virus was replicating in the mice significantly (see Results).
Because of evidence that the antibody response to certain bacterial and virus antigens is thymus independent (see Feldmann & Basten, 1971 ) the thymus dependency of the antihexon and anti-fibre responses was tested. Whether immunization was with isolated antigens or whole virus, there was a consistent tenfold or greater difference between thymectomized and control mice in antibody titres to both antigens, so that both are largely thymus dependent. Particularly after whole virus immunization, however, the thymectomized mice made substantial antibody responses to hexon. This can be construed in three ways. First, thymectomized mice prepared in this way are not totally thymus deprived and strong immunization may help to stimulate their residual 5 to Io % of thymus derived (T) cells (Raft & Wortis, I97O) . Secondly, it is known that if mice have been immunized in advance, thymectomy does not alter their responsiveness, even to fully thymus dependent antigens (Cross, Leuchars & Davies, I964) . In view of the background antibody found in these mice, this may explain the apparent thymus independence of hexon. Finally, the anti-hexon response may indeed be partly thymus independent, especially after whole virus immunization, and this may be attributed to the favourable epitope density achieved on the capsid surface. Indeed all thymus independent antigens reported to date do have repeating determinants (see Basten & Howard, I973) . The first explanation is particularly likely in the case of fibre, which, when presented in whole virus, is very much more immunogenic than in isolated form.
The fact that T cells can recognize the isolated antigens suggests that it may be possible to elicit T cell-mediated immunity to them, perhaps with the aid of appropriate adjuvants (Dresser & Phillips, I973) . This may prove to be important in a general context, as cell mediated immunity plays a crucial role in resistance to several virus diseases (Allison, 1972) , and may also do so in tumour immunity. Indeed, this work may be especially relevant to the possibility of vaccination with oncogenic virus antigens.
Immunity against both hexon and fibre protected the mice against a lethal dose of virus, which correlated with the ability of antibody against both antigens to neutralize virus in vitro and in vivo. Further, cell transfer experiments indicated an absolute requirement for circulating antibody. In this system, spleen cells transferred from immunized donors made no antibody in their adoptive hosts without an antigen boost. Although these recipients had considerable numbers of primed lymphocytes, they died after challenge, whereas those which made antibody after an antigen boost survived. This indicated that cell-mediated immunity alone was insufficient for protection, and also that the challenge dose of virus could not elicit a secondary antibody response in time to protect the mice. Moreover, immunity could only be passively transferred by antibody within hours of challenge; if it was delayed by 6 h it was too late to protect the mice. Hence it is unlikely that long-term immunological memory could play any role in this system.
Protection by anti-hexon and anti-fibre immunity was largely type-specific. In the case of fibre, this is not surprising, as the type-specific determinants are probably located distally and would therefore be more accessible than the subgroup-specific sites in intact virus (Philipson, Lonberg-Holm & Pettersson, 1968 ) and in addition most of the fibre antibody made is type-specific (H. N. A. Willcox & V. Mautner, unpublished observations). With hexon it is more remarkable since the vast majority of the antibody is group-specific and in vitro, group-specific antibody can bind to virus and sensitize it for neutralization with anti-globulin serum (Wadell, 1972) . It seems that the type-specific antibody must be inter-acting at some critical site on the virus to be so effective in such small amounts. It is apparent that whole virus is somewhat more immunogenic than the isolated antigens, but the quality of the antibody made, in terms of the proportion of type-specific antibody, is not very different. There may even be some slight disadvantage in using whole virus to immunize in that the anti-hexon response tends to predominate over the anti-fibre response, and it is the latter that gives rise to proportionately more type-specific neutralizing antibody.
The pathogenesis of the disease in mice is still being investigated. One possible mechanism is a massive direct cytotoxic effect of the virus on the hepatocytes; there is an in vitro precedent for this in the case of mouse L cells, where a c.p.e, occurs without replication of virus. However, u.v.-irradiated virus, which can be cytopathic for cells in tissue culture, does not produce the disease in mice, and neither are the isolated proteins toxic for mice. A second possibility is that an abortive cycle of replication occurs, which also kills the hepatocytes. This is supported by the detection of the early P antigen (see Russell, I97I) Because of these uncertainties about the pathogenesis of the disease, discussion of the mechanism of protection is necessarily speculative. In other virus systems, both humoral and cell-mediated immunity have been implicated. Because of the probable absence of complete virus replication in the mouse, this system emphasizes protection in the initial stages of infection; in other words we are not in a position to discuss prevention of virus spread. Some of the features of protection are probably a reflection of the unusually large doses of virus required to produce this particular disease syndrome.
